Kangji Medical Holdings (HKSE:09997) 3-Year EBITDA Growth Rate : 14.10% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings 3-Year EBITDA Growth Rate?

Kangji Medical Holdings's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.31.

During the past 12 months, Kangji Medical Holdings's average EBITDA Per Share Growth Rate was 7.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 14.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 18.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kangji Medical Holdings was 34.80% per year. The lowest was 14.10% per year. And the median was 23.00% per year.

Competitive Comparison of Kangji Medical Holdings's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kangji Medical Holdings's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's 3-Year EBITDA Growth Rate falls into.

Kangji Medical Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kangji Medical Holdings (HKSE:09997) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kangji Medical Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangji Medical Holdings (HKSE:09997) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

50J:Germany

Address

No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN

Website

https://www.kangjimedical.com

Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines